Concepedia

Publication | Open Access

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

DOIFull Paper Access

301

Citations

16

References

2005

Year

Katherine R. Tuttle, George L. Bakris, Robert D. Toto, Janet B. McGill, Kuolung Hu, Pamela W. Anderson
Diabetes Care

Abstract

In persons with type 2 diabetes and nephropathy, treatment with ruboxistaurin reduced albuminuria and maintained eGFR over 1 year. Ruboxistaurin may add benefit to established therapies for diabetic nephropathy.

References

YearCitations

Page 1